Carrie S. Cox
Carrie Cox serves as Chairman of Organon’s Board of Directors. Ms. Cox most recently served as Executive Chairman of Humacyte, Inc. until 2019, a then privately-held regenerative medical technology company, where she also held the title of Chief Executive Officer from 2010 to 2018. Ms. Cox served as Executive Vice President of Schering-Plough Corporation and President of Schering-Plough’s global pharmaceutical business from 2003 until 2009, when Schering-Plough merged with Merck & Co., Inc. Prior to joining Schering-Plough, Ms. Cox served as President of Pharmacia Corporation’s global pharmaceutical business from 1997 until its merger with Pfizer Inc. in 2003. She also currently serves on the board of directors of Texas Instruments Inc. (since 2004), Cardinal Health Inc. (since 2009), and Selecta Biosciences, Inc. (since 2019). She was previously chair of the boards of Array BioPharma, Inc. from 2018 until its acquisition by Pfizer Inc. in 2019, and electroCore, Inc. from 2018 to 2019, and served on the board of directors of Celgene Corp. from 2009 until its acquisition by Bristol-Myers Squibb Co. in 2019. Ms. Cox is a graduate of the Massachusetts College of Pharmacy.